Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine for postoperative shivering, nausea, and vomiting in opium-addicted neurosurgical patients
IRCT20201122049464N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Dec 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine in postanesthetic shivering (PAS) and postoperative nausea and vomiting (PONV) (2 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Postoperative shivering, Postoperative nausea and 1 more. Started Dec 2020; status: completed.
02
Drugs
dexmedetomidine
03
Conditions
postanesthetic shivering (PAS)postoperative nausea and vomiting (PONV)
Beyond the preview
Go deeper on IRCT20201122049464N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201122049464N1.